Takeshi Tanoue

USPTO Granted Patents = 34 (Patent Applications = 6)

CIPO Patents = 1

EPO Patents = 8 (Patent Applications = 10)

Average Co-Inventor Count = 4.4

ph-index = 16

Forward Citations = 778(Granted Patents)

Location History:

Yokohama, JP (2017 - 2018)
Tokyo, JP (2016 - 2023)

Company Filing History:

31 out of 1,285

The University of Tokyo

patents

9 out of 14

School Corporation, Azabu Veterinary Medicine Educational Institution

Vedanta Biosciences, Inc.

School Corporation, Azabu Veterinary Medicine Educational Institute

patent

where one patent can have more than one assignee

Years Active: 2016-2025

Loading Chart...

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12409196 - Composition for inducing proliferation or accumulation of regulatory T cells (2025-09-09),

2. 12214003 - Composition for inducing proliferation or accumulation of regulatory T cells (2025-02-04),

3. 11723934 - Compositions and methods for the induction of CD8+ T-cells (2023-08-15),

4. 11633465 - Compositions and methods for the induction of CD8+ T-cells (2023-04-25),

5. 11547732 - Human-derived bacteria that induce proliferation or accumulation of regulatory T cells (2023-01-10),

6. 11167018 - Compositions and methods for the induction of CD8+ T-cells (2021-11-09),

7. 11090343 - Composition for inducing proliferation or accumulation of regulatory T cells (2021-08-17),

8. 10835559 - Human-derived bacteria that induce proliferation or accumulation of regulatory T cells (2020-11-17),

9. 10695412 - Compositions and methods for the induction of CD8+ T-cells (2020-06-30),

10. 10624933 - Human-derived bacteria that induce proliferation or accumulation of regulatory T cells (2020-04-21),

11. 10588925 - Composition for inducing proliferation or accumulation of regulatory T cells (2020-03-17),

12. 10576136 - Compositions and methods for the induction of CD8+ T-cells (2020-03-03),

13. 10555978 - Composition for inducing proliferation or accumulation of regulatory T cells (2020-02-11),

14. 10342832 - Human-derived bacteria that induce proliferation or accumulation of (2019-07-09),

15. 10328108 - Composition for inducing proliferation or accumulation of regulatory T cells (2019-06-25),

Sure, here is the article based on the data provided:

Title: The Brilliant Mind of Takeshi Tanoue: Paving the Way for CD8+ T-Cell Innovations

Introduction:

Takeshi Tanoue, a distinguished inventor based in Tokyo, Japan, has made significant contributions to the field of immunology with his groundbreaking research on CD8+ T-cells. With an impressive portfolio of 32 patents, Tanoue's work has not only advanced scientific knowledge but also holds immense promise for the treatment of various diseases.

Latest Patents:

Tanoue's latest patents revolve around compositions and methods for the induction and proliferation of CD8+ T-cells. These innovations offer novel approaches for enhancing the body's immune response and have the potential to revolutionize disease treatment strategies by leveraging the power of CD8+ T-cells.

Career Highlights:

Having worked at esteemed institutions such as The University of Tokyo and the School Corporation, Azabu Veterinary Medicine Educational Institution, Tanoue has demonstrated a relentless commitment to research and innovation. His drive to push the boundaries of science has led to the development of cutting-edge technologies with far-reaching implications.

Collaborations:

Throughout his career, Tanoue has collaborated closely with esteemed colleagues such as Kenya Honda and Koji Atarashi. These collaborations have not only enriched his research endeavors but have also fostered a culture of innovation and knowledge sharing within the scientific community.

Conclusion:

In conclusion, Takeshi Tanoue stands as a beacon of innovation in the field of immunology, with his pioneering work on CD8+ T-cells shaping the future of disease treatment. His dedication to scientific excellence and his collaborative spirit continue to inspire fellow researchers and pave the way for transformative advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.